FR2986156B1 - Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif - Google Patents

Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Info

Publication number
FR2986156B1
FR2986156B1 FR1250851A FR1250851A FR2986156B1 FR 2986156 B1 FR2986156 B1 FR 2986156B1 FR 1250851 A FR1250851 A FR 1250851A FR 1250851 A FR1250851 A FR 1250851A FR 2986156 B1 FR2986156 B1 FR 2986156B1
Authority
FR
France
Prior art keywords
transdermic
patient
active ingredient
controlled administration
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1250851A
Other languages
English (en)
Other versions
FR2986156A1 (fr
Inventor
Michel Faupel
Serge Bischoff
Florian George
Peter Stark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RHENOVIA PHARMA
Original Assignee
RHENOVIA PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1250851A priority Critical patent/FR2986156B1/fr
Application filed by RHENOVIA PHARMA filed Critical RHENOVIA PHARMA
Priority to US14/373,923 priority patent/US9782482B2/en
Priority to EP13712825.2A priority patent/EP2809302A1/fr
Priority to CN201380007389.6A priority patent/CN104244924A/zh
Priority to KR1020147021691A priority patent/KR20140116898A/ko
Priority to PCT/FR2013/000028 priority patent/WO2013114011A1/fr
Priority to RU2014133757A priority patent/RU2014133757A/ru
Priority to CA2861527A priority patent/CA2861527A1/fr
Priority to JP2014553775A priority patent/JP2015511832A/ja
Publication of FR2986156A1 publication Critical patent/FR2986156A1/fr
Application granted granted Critical
Publication of FR2986156B1 publication Critical patent/FR2986156B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A61N2005/0652—Arrays of diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
FR1250851A 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif Expired - Fee Related FR2986156B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR1250851A FR2986156B1 (fr) 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif
EP13712825.2A EP2809302A1 (fr) 2012-01-30 2013-01-30 Dispositif transdermioue pour l'administration contrôlée a un patient d'au moins un principe actif
CN201380007389.6A CN104244924A (zh) 2012-01-30 2013-01-30 用于向患者受控给药至少一种活性成分的透皮装置
KR1020147021691A KR20140116898A (ko) 2012-01-30 2013-01-30 환자에 적어도 하나의 활성 성분을 조절 투여하기 위한 경피용 장치
US14/373,923 US9782482B2 (en) 2012-01-30 2013-01-30 Transdermal device for the controlled administration of at least one active ingredient to a patient
PCT/FR2013/000028 WO2013114011A1 (fr) 2012-01-30 2013-01-30 Dispositif transdermioue pour l'administration contrôlée a un patient d'au moins un principe actif
RU2014133757A RU2014133757A (ru) 2012-01-30 2013-01-30 Прибор для управляемого введения пациенту через кожу по крайней мере одного активного ингредиента
CA2861527A CA2861527A1 (fr) 2012-01-30 2013-01-30 Dispositif transdermioue pour l'administration controlee a un patient d'au moins un principe actif
JP2014553775A JP2015511832A (ja) 2012-01-30 2013-01-30 少なくとも１つの有効成分を制御して患者に投与するための経皮投与装置

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1250851A FR2986156B1 (fr) 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Publications (2)

Publication Number Publication Date
FR2986156A1 FR2986156A1 (fr) 2013-08-02
FR2986156B1 true FR2986156B1 (fr) 2014-07-04

Family

ID=48014039

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1250851A Expired - Fee Related FR2986156B1 (fr) 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Country Status (9)

Country Link
US (1) US9782482B2 (fr)
EP (1) EP2809302A1 (fr)
JP (1) JP2015511832A (fr)
KR (1) KR20140116898A (fr)
CN (1) CN104244924A (fr)
CA (1) CA2861527A1 (fr)
FR (1) FR2986156B1 (fr)
RU (1) RU2014133757A (fr)
WO (1) WO2013114011A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105530867B (zh) * 2013-08-21 2018-11-13 传感技术股份有限公司 用于生物感测分析物的体内保护的药物洗脱
FR3034021B1 (fr) * 2015-03-23 2021-01-08 Lucibel Dispositif de phototherapie deformable
FR3034023B1 (fr) * 2015-03-23 2021-01-08 Lucibel Dispositif de traitement cutane
US10596388B2 (en) 2016-09-21 2020-03-24 Epistar Corporation Therapeutic light-emitting module
JP6972334B2 (ja) * 2017-11-14 2021-11-24 イー インク カリフォルニア， エルエルシー 多孔性伝導電極層を含む電気泳動活性分子送達システム
KR20220074962A (ko) 2019-11-27 2022-06-03 이 잉크 캘리포니아 엘엘씨 전기 침식 밀봉층을 갖는 마이크로셀들을 포함하는 유익제 전달 시스템
EP4205807A1 (fr) * 2021-12-30 2023-07-05 Paul Hartmann AG Pansement destiné au traitement antimicrobien des plaies
EP4205808A1 (fr) * 2021-12-30 2023-07-05 Paul Hartmann AG Dispositif de traitement antimicrobien des plaies

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662531B2 (en) * 1991-06-12 1995-09-07 Mcneil-Ppc, Inc. Melt blown menstrual pad for application to the body
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
JPH09512006A (ja) * 1994-04-13 1997-12-02 チバ−ガイギー アクチェンゲゼルシャフト 時間的に調節された薬物供給システム
AU2002241834B2 (en) * 2001-01-09 2006-11-09 Microchips, Inc. Flexible microchip devices for opthalmic and other applications
CN2533890Y (zh) * 2002-02-11 2003-02-05 叶延程 药物透皮控释装置
US20040122500A1 (en) * 2002-12-19 2004-06-24 Kimberly-Clark Worldwide, Inc. Electrode for utilizing edge effect to create uniform current density
AU2003303525A1 (en) * 2002-12-31 2004-07-29 Ultra-Sonic Technologies, L.L.C. Transdermal delivery using encapsulated agent activated by ultrasound and/or heat
WO2006015299A2 (fr) * 2004-07-30 2006-02-09 Microchips, Inc. Dispositif multi-reservoir pour la delivrance de medicament transdermique et la detection
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US8936590B2 (en) * 2005-11-09 2015-01-20 The Invention Science Fund I, Llc Acoustically controlled reaction device
DE102006023186B4 (de) * 2006-05-17 2012-02-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Transdermales therapeutisches System
US20080058907A1 (en) * 2006-08-30 2008-03-06 Reuben David I Self Sanitizing Bandage with Built-In Ultraviolet LED
US7666179B2 (en) * 2006-10-10 2010-02-23 Boston Scientific Scimed, Inc. Medical devices having porous regions for controlled therapeutic agent exposure or delivery
US8206326B2 (en) * 2008-03-04 2012-06-26 Sound Surgical Technologies, Llc Combination ultrasound-phototherapy transducer
GB0821862D0 (en) * 2008-12-01 2009-01-07 Lumicure Ltd Light Emitting apparatus
US8163834B2 (en) * 2009-03-18 2012-04-24 Dublin City University Photoresponsive ionogel
JP6158082B2 (ja) * 2010-07-17 2017-07-05 メルク パテント ゲーエムベーハー 浸透と作用の増強
WO2012035429A2 (fr) * 2010-09-13 2012-03-22 The University Of British Columbia Systèmes d'administration de médicament télécommandés
US20120289885A1 (en) * 2011-05-14 2012-11-15 William Jude Cottrell Phototherapy system

Also Published As

Publication number Publication date
EP2809302A1 (fr) 2014-12-10
CA2861527A1 (fr) 2013-08-08
US20150018749A1 (en) 2015-01-15
KR20140116898A (ko) 2014-10-06
WO2013114011A8 (fr) 2014-08-28
WO2013114011A1 (fr) 2013-08-08
US9782482B2 (en) 2017-10-10
RU2014133757A (ru) 2016-03-20
FR2986156A1 (fr) 2013-08-02
CN104244924A (zh) 2014-12-24
JP2015511832A (ja) 2015-04-23

Similar Documents

Publication Publication Date Title
FR2986156B1 (fr) Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif
MA41818A (fr) Timbre à micro-aiguilles pour administration d'un principe actif à la peau
IT1403780B1 (it) Dispositivo per l'infusione di farmaci.
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
WO2013170068A3 (fr) Modulateurs du transport nucléaire et leurs utilisations
BR112015021983A2 (pt) compostos heterocíclicos e usos dos mesmos
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
WO2014205389A8 (fr) Modulateurs de transport nucléaire et leurs utilisations
BR302012004398S1 (pt) "configuração aplicada em dispositivo médico"
SMT201500184B (it) Sistema terapeutico transdermico per somministrareun principio attivo
EP2823819A4 (fr) Composition pharmaceutique contenant de l'acétate d'acide oléanolïque en tant que principe actif pour la prévention ou le traitement de maladie à médiation par tlr ou il-6
FR2987744B1 (fr) Principe actif obtenu a partir de cichorium intybus pour une action sur la fonction barriere de la peau similaire a celle de la vitamine d
SMT201600341B (it) Soluzione per somministrazione orale
BR302012005965S1 (pt) "configuração aplicada a bomba de dosagem"
FR2972650B1 (fr) Dispositif d'administration de fluides
FR3002144B1 (fr) Composition galenique adaptee a l'administration a un animal non-humain
MX360002B (es) Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento.
FR2973708B1 (fr) Dispositif d'assistance respiratoire
CL2015002933A1 (es) Identificación de la respuesta del paciente a la administración de un modulador del receptor s1p.
FR3000896B1 (fr) Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR2998174B1 (fr) Procede de preparation d'un principe actif cosmetique ou dermatologique
EP2567710A4 (fr) Système pharmaceutique aqueux pour l'administration de médicaments au niveau des ongles
FR2998801B1 (fr) Ensemble a usage medical pour l'administration d'un produit a un patient
BR112014032264A2 (pt) composiçâo para tratamento ou prevençâo de doenças relacionadas á permeabilidade vascular, contendo imatinibe ou um sal farmaceuticamente aceitável respectivo como ingrediente ativo
FR2995536B1 (fr) Unite medicale pour l'injection de rubidium 82 a un patient

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20180928